Meet Samuel – Your Personal Investing Prophet
High conviction TEM bulls now have this Tradr ETFTempus AI, Inc. Class A ( (TEM) ) has provided an update.
On May 7, 2026, Tempus AI announced a private offering of $350 million in Convertible Senior Notes due 2032, with an option for an additional $52.5 million, aimed at optimizing its capital structure and reducing interest expense. The notes, which are unsecured and convertible into cash, Class A common stock or a mix of both, are being sold to qualified institutional buyers and will be paired with capped call transactions designed to limit dilution for existing shareholders.
Tempus stated it expects to use most of the net proceeds to repay approximately $307.7 million of senior secured credit facilities, fund capped call hedges and support general corporate purposes including potential acquisitions, investments and working capital. On May 12, 2026, the company followed through by using a portion of the offering proceeds to fully repay and terminate its 2022 credit agreement with Ares Capital and related security arrangements, a move that reduces secured debt and is intended to enhance financial flexibility and improve its interest cost profile.
The most recent analyst rating on (TEM) stock is a Hold with a $58.00 price target. To see the full list of analyst forecasts on Tempus AI, Inc. Class A stock, see the TEM Stock Forecast page.
Spark’s Take on TEM Stock
According to Spark, TipRanks’ AI Analyst, TEM is a Neutral.
Overall score is held down primarily by weak financial performance (ongoing operating losses, negative operating/free cash flow, and elevated debt), with technicals also reflecting a broader downtrend. The main support comes from the earnings call, where raised 2026 guidance, strong YoY growth, and improving EBITDA trajectory offset some risk, while valuation remains constrained by current losses and no dividend support.
To see Spark’s full report on TEM stock, click here.
More about Tempus AI, Inc. Class A
Tempus AI, Inc. is a Chicago-based technology company focused on advancing precision medicine through the application of artificial intelligence in healthcare. Leveraging one of the world’s largest libraries of multimodal clinical and molecular data and a dedicated operating system, it provides AI-enabled tools to physicians and biopharma partners to support personalized patient care and the discovery and development of therapeutics.
Average Trading Volume: 5,643,088
Technical Sentiment Signal: Sell
Current Market Cap: $8.43B
Learn more about TEM stock on TipRanks’ Stock Analysis page.